EUVIMEDEUVIMED entdecken
Open Access

Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications

Pengfei Liang, Yui-Chun S Wan, Ke Z Shan, Ryan Chou, Yang Zhang, Martha Delahunty, Sanjay Khandelwal iD, Samuel J Francis, Gowthami M Arepally, Marilyn J Telen, Huanghe Yang iD

American Journal of Hematology · 2025-12 · 100 (12) · 2261-2275

DOI: 10.1002/ajh.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 08.10.2025. Verfasst von Pengfei Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Anoctamins, Phospholipid Transfer Proteins, Ion Channels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, American Society of Hematology Graduate Hematology Award to Yuichun Wan Scholar Award to Pengfei Liang, American Society of Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A deeper understanding of sickle cell disease (SCD) pathophysiology is critical for identifying novel therapeutic targets. A hallmark of SCD is abnormal phosphatidylserine (PS) exposure on sickle red blood cells (RBCs), which contributes to anemia, thrombosis, and vaso‐occlusive crises (VOC). However, the mechanisms underlying this excessive PS exposure remain unclear. Here, we identify TMEM16F, a Ca 2+ ‐activated lipid scramblase, as a key mediator of PS exposure downstream of Ca 2+ influx through the mechanosensitive channel PIEZO1 in sickle RBCs. Electrophysiology, imaging, and flow cytometry reveal that deoxygenation‐induced sickling activates PIEZO1, triggering Ca 2+ entry, TMEM16F activation, and PS exposure. This cascade promotes PS + microparticle release, thrombin generation, and RBC adhesion to endothelial cells. Notably, partial PIEZO1 inhibition with benzbromarone, an anti‐gout drug, suppresses these effects. Our findings define a previously unrecognized mechanotransduction pathway in sickle RBCs and propose a unique therapeutic strategy to mitigate hypercoagulability and vaso‐occlusion associated with SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellAnoctaminsPhospholipid Transfer ProteinsIon ChannelsHumansPhosphatidylserinesErythrocytes, AbnormalCalciumMechanotransduction, CellularErythrocytes

Substanzen

PIEZO1 protein, humanAnoctaminsPhosphatidylserinesPhospholipid Transfer ProteinsANO6 protein, humanIon ChannelsCalcium

Autor:innen und Institutionen

  • Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Sanjay Khandelwal, Huanghe Yang

Förderung

  • NIGMS NIH HHS
  • American Society of Hematology Graduate Hematology Award to Yuichun Wan Scholar Award to Pengfei Liang
  • American Society of Hematology
  • National Institute of General Medical Sciences

Zitieren

APA

Liang, P., Wan, Y. S., Shan, K. Z., Chou, R., Zhang, Y., Delahunty, M., Khandelwal, S., Francis, S. J., Arepally, G. M., Telen, M. J., & Yang, H. (2025). Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications. American Journal of Hematology, 100(12), 2261-2275. https://doi.org/10.1002/ajh.70086

Vancouver

Liang P, Wan YS, Shan KZ, Chou R, Zhang Y, Delahunty M, et al. Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications. American Journal of Hematology. 2025;100(12):2261-2275. doi:10.1002/ajh.70086

BibTeX
@article{Liang2025,
  author = {Liang, Pengfei and Wan, Yui-Chun S and Shan, Ke Z and Chou, Ryan and Zhang, Yang and Delahunty, Martha and Khandelwal, Sanjay and Francis, Samuel J and Arepally, Gowthami M and Telen, Marilyn J and Yang, Huanghe},
  title = {Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications},
  journal = {American Journal of Hematology},
  year = {2025},
  volume = {100},
  number = {12},
  pages = {2261--2275},
  doi = {10.1002/ajh.70086}
}
Kostenlos starten →